[LSIC x LSN] Joint Webinar for Japanese Life Science Community

21 Mar

By Claire Jeong, Chief Conference Officer, Vice President of Investor Research, Asia BD, LSN

I am very excited to announce that Life Science Nation (LSN) and Life Science Incubation Council (LSIC) has signed a MoU to work together to support the life science ecosystem in Japan!

Established in 2022, Life Science Incubation Council is a Japanese organization that has created a platform on which key players in the sector such as start-ups, VCs, pharmaceutical companies, medical device companies and government organizations can work together to develop innovative technology seeds, aiming towards commercialization of these technologies. LSIC and LSN signed a MoU to work together for the development of the Japanese life science industry on a global scale.

On Wednesday, March 27, 7:00 – 8:30pm EST / Thursday, March 28, 8:00 – 9:30am JST, LSN and LSIC will be organizing a 90-minute webinar including an introduction of LSN’s platform and our value-add for the global life science ecosystem, remarks from panelists who are familiar with LSN and have leveraged our platform, and pitches from companies developing innovative therapeutics. We expect over 150 people in attendance, including startups, investors, pharmaceuticals, and more. The webinar will be held in English, and everyone is welcome to join.

Please find our program below.

Time (JST)  Topic  Speakers 
8:00 – 8:05 Opening Remarks 
  • Nao Yoshizawa, CEO, Life Science Incubation Council
8:05 – 8:35 Introduction of LSN (30 minutes) 
  • Dennis Ford, CEO, Life Science Nation
  • Claire Jeong, VP of Investor Research, Asia BD, Life Science Nation
  • Karen Deyo, VP of Product, Life Science Nation
8:35 – 9:00 Success Stories and Experiences from LSN Network (25 minutes) 
  • Toru Jay Seo, CEO, Newsight Tech Angels
  • Yao Li Ho, Managing Director, LYFE Capital
  • Thomas Forest Farb-Horch, CEO, Thrive Bioscience
9:00 – 9:25 Innovative Drug Pipelines of LSN Clients (25 minutes) 
  • Upendra Marathi, President and CEO, 7 Hills Pharma
  • Brenton Hamdorf, Executive Director & Chief Executive Officer, Celosia Therapeutics
  • Kay Olmstead, Chief Executive Officer, Nano PharmaSolutions
  • Richard Austin, CEO, Reglagene
  • Frank Luppino, President and CEO, Remedium Bio
9:25 – 9:30 Q&A / Closing Remarks 

RESI-South-2024_02062024.

Register-now-button-new

RESI-Europe-2024-Banner-1100pxw

Leave a comment